Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

A Randomized Phase II/III Study of R-THP-Cop Vs R-CHOP for Patients Younger Than 70 Years with DLBCL

Naoe Goto, MD PhD, Takuro Matsumoto, MD, Yuhei Shibata, MD, Junichi Kitagawa, MD PhD, Nobuhiro Kanemura, MD PhD, Yoshikawa Takeshi, MDPhD, Senji Kasahara, MD PhD, Hideko Goto, MDPhD, Kenji Fukuno, MD, Takeshi Hara, MD PhD, Toshiki Yamada, MD PhD, Michio Sawada, MD PhD, Takeshi Takahashi, MDPhD, Koshiro Saito, MD PhD, Hisataka Moriwaki, Prof., Hisashi Tsurumi, MD PhD

Blood (2014) 124 (21): 3078.

https://doi.org/10.1182/blood.V124.21.3078.3078

Published: 2014

Journal Articles

Combination Of Indoleamine 2,3-Dioxygenase Inhibitor and Cytotoxic Agents Is a Novel Therapeutic Option For Non-Hodgkin Lymphoma

Nobuhiko Nakamura, MD, Takeshi Hara, MD, PhD, Yuhei Shibata, MD, Takuro Matsumoto, MD, Ryoko Mabuchi, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD, PhD, Nobuhiro Kanemura, MD, PhD, Naoe Goto, MD, PhD, Masahito Shimizu, MD, PhD, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki

Blood (2013) 122 (21): 4408.

https://doi.org/10.1182/blood.V122.21.4408.4408

Published: 2013

Journal Articles

Serum IL-10 and IL-8 Among Variable Cytokines Derived From Helper T Cells Might Be Associated with Prognoses for Malignant Lymphoma Patients

Junichi Kitagawa, MD, PhD, Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, PhD, Katsuyoshi Takata, MD, PhD, Nobuhiko Nakamura, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Senji Kasahara, MD, PhD, Takeshi Takahashi, MD, PhD, Tadashi Yoshino, Prof., Hisataka Moriwaki, Prof.

Blood (2012) 120 (21): 5107.

https://doi.org/10.1182/blood.V120.21.5107.5107

Published: 2012

Journal Articles

Prognositc Inpact of Tumor-Infiltrating FOXP3 + Regulatory T Cells in DLBCL Treated with R-CHOP

Naoe Goto, MD, PhD, Hisashi Tsurumi, MD, PhD, Yuhei Shibata, MD, Ryoko Mabuchi, MD, Nobuhiko Nakamura, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2012) 120 (21): 1555.

https://doi.org/10.1182/blood.V120.21.1555.1555

Published: 2012

Journal Articles

Combination of Indoleamine 2,3-Dioxygenase Expression and L-Kynurenine Level Can Identify Truly Poor Prognosis Patients with Diffuse Large B-Cell Lymphoma

Soranobu Ninomiya, MD, Nobuhiro Kanemura, MD, PhD, Hisashi Tsurumi, MD, PhD, Naoe Goto, MD, PhD, Ryoko Mabuchi, MD, Nobuhiko Nakamura, MD, Hiroshi Nakamura, MD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 2639.

https://doi.org/10.1182/blood.V118.21.2639.2639

Published: 2011

Journal Articles

Tryptophan Catabolism Is Associated with the Prognosis of Patients with De Novo Acute Myeloid Leukemia,

Hisashi Tsurumi, MD, PhD, Nobuhiro Kanemura, MD, PhD, Kenji Fukuno, MD, Junji Nagano, MD, Kengo Ogawa, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 3541.

https://doi.org/10.1182/blood.V118.21.3541.3541

Published: 2011

Journal Articles

Prognositc Inpact of Tumor-Infiltrating Cells Especially CD163 Positive Macrophage in DLBCL Treated with R-CHOP

Naoe Goto, MD, PhD, Nobuhiro Kanemura, MD, PhD, Hisashi Tsurumi, MD, PhD, Nobuhiko Nakamura, MD, Senji Kasahara, MD, PhD, Takeshi Hara, MD, PhD, Hisataka Moriwaki, Tsuyoshi Takami

Blood (2011) 118 (21): 1594.

https://doi.org/10.1182/blood.V118.21.1594.1594

Published: 2011

Journal Articles

Clinical Significance of Serum Concentration of L-Kynurenine for T-Cell Lymphoma Treated with CHOP

Nobuhiro Kanemura, MD, PhD, Hisashi Tsurumi, MD, PhD, Junji Nagano, MD, Takeshi Hara, MD, PhD, Kengo Ogawa, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Hisataka Moriwaki, Prof.

Blood (2011) 118 (21): 1598.

https://doi.org/10.1182/blood.V118.21.1598.1598

Published: 2011

Journal Articles

Serum Soluble Tumor Necrosis Factor Recepter 2 Levels Is Associated with the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Regimen

Nobuhiko Nakamura, MD, Naoe Goto, MD, PhD, Hisashi Tsurumi, MD, PhD, Masao Takemura, PhD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Senji Kasahara, Md, PhD, Mitsuru Seishima, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2011) 118 (21): 1575.

https://doi.org/10.1182/blood.V118.21.1575.1575

Published: 2011

Journal Articles

Clinical Significance of Small Intestinal Involvement Detected by Double-Balloon Enteroscopy In Patients with Non-Hodgkin's Lymphoma

Hisashi Tsurumi, MD, PhD, Takashi Ibuka, MD, Takeshi Hara, MD, PhD, Hiroshi Araki, MD, Soranobu Ninomiya, MD, Naoe Goto, MD, PhD, Humito Onogi, MD, PhD, Nobuhiro Kanemura, MD, PhD, Senji Kasahara, MD, PhD, Tomohiro Kato, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 5075.

https://doi.org/10.1182/blood.V116.21.5075.5075

Published: 2010

Journal Articles

Clinical Impact of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy In the Diagnosis of Patients with Lymphoma Who Have No Superficial Lymphadenopathies

Naoe Goto, MD, PhD, Ichiro Yasuda, MD, PhD, Hisashi Tsurumi, MD, PhD, Shinpei Doi, MD, Takeshi Hara, MD, PhD, Takuji Iwashita, MD, PhD, Senji Kasahara, MD, PhD, Masanori Nakashima, MD, Nobuhiro Kanemura, MD, PhD, Seiji Adachi, MD, PhD, Takahiro Yamauchi, MD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 5083.

https://doi.org/10.1182/blood.V116.21.5083.5083

Published: 2010

Journal Articles

Tryptophan Catabolism Is Associated with Clinical Outcome of Patients with Malignant Lymphoma

Soranobu Ninomiya, MD, Hisashi Tsurumi, MD, PhD, Takeshi Hara, MD, PhD, Masato Hoshi, Naoe Goto, MD, PhD, Nobuhiro Kanemura, MD, PhD, Senji Kasahara, MD, PhD, Masahito Shimizu, MD, PhD, Kuniaki Saito, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 4146.

https://doi.org/10.1182/blood.V116.21.4146.4146

Published: 2010

Journal Articles

Expression of IDO (indoleamine 2,3-dioxygenase) In Blasts of Acute Myeloid Leukemia Patients Predicts Poor Clinical Outcome

Nobuhiko Nakamura, MD, Soranobu Ninomiya, MD, Takeshi Hara, MD, PhD, Kenji Fukuno, MD, Masato Hoshi, PhD, Nobuhiro Kanemura, MD, PhD, Naoe Goto, MD, PhD, Senji Kasahara, MD, PhD, Kuniaki Saito, PhD, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 4379.

https://doi.org/10.1182/blood.V116.21.4379.4379

Published: 2010

Journal Articles

Serum Soluble Interleukin-2 Level Determines Clinical Outcome In Patients with Follicular Lymphoma In Rituximab Era

Senji Kasahara, MD, PhD, Naoe Goto, MD, PhD, Hisashi Tsurumi, MD, PhD, Nobuhiro Nakamura, MD, Hiroshi Nakamura, MD, Nobuhiro Kanemura, MD, PhD, Takeshi Hara, MD, PhD, Tsuyoshi Takami, MD, PhD, Hisataka Moriwaki, MD, PhD

Blood (2010) 116 (21): 3106.

https://doi.org/10.1182/blood.V116.21.3106.3106

Published: 2010

Journal Articles

Serum Interleukin-18 Level Determines Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era.

Naoe Goto, Hisashi Tsurumi, MD, PhD, Senji Kasahara, Takeshi Hara, Nobuhiro Kanemura, Takeshi Yoshikawa, Soranobu Ninomiya, Kengo Ogawa, Toshiki Yamada, MD, Michio Sawada, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2009) 114 (22): 1926.

https://doi.org/10.1182/blood.V114.22.1926.1926

Published: 2009

Journal Articles

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Soranobu Ninomiya, Nobuhiro Kanemura, Hisashi Tsurumi, MD, PhD, Takeshi Hara, Naoe Goto, Takeshi Yoshikawa, Senji Kasahara, Masahito Shimizu, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2009) 114 (22): 2924.

https://doi.org/10.1182/blood.V114.22.2924.2924

Published: 2009

Journal Articles

Serum Concentration of L-Kynurenine Can Determine Clinical Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Soranobu Ninomiya, Hisashi Tsurumi, MD, PhD, Takeshi Hara, Naoe Goto, Takeshi Yoshikawa, Junichi Kitagawa, Nobuhiro Kanemura, Senji Kasahara, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2008) 112 (11): 2812.

https://doi.org/10.1182/blood.V112.11.2812.2812

Published: 2008

Journal Articles

A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma

Hisashi Tsurumi, MD, PhD, Naoe Goto, Takeshi Hara, Senji Kasahara, Nobuhiro Kanemura, Junichi Kitagawa, MD, Takeshi Yoshikawa, Toshiki Yamada, Michio Sawada, Takeshi Takahashi, Tsuyoshi Takami, Hisataka Moriwaki

Blood (2008) 112 (11): 3599.

https://doi.org/10.1182/blood.V112.11.3599.3599

Published: 2008

Journal Articles

Synergistic Growth Inhibition by the Combination of Acyclic Retinoid Plus Vitamin K 2 in HL-60 Cells

Junichi Kitagawa, Senji Kasahara, Takeshi Hara, Nobuhiro Kanemura, Masahito Shimizu, Hisashi Tsurumi, MD, PhD, Hisataka Moriwaki

Blood (2008) 112 (11): 5027.

https://doi.org/10.1182/blood.V112.11.5027.5027

Published: 2008

Journal Articles

Second Report of Clinical Significance of sFas for DLBCL Treated with CHOP and New Analysis of sFas for DLBCL Treated with R-CHOP.

Hisashi Tsurumi, Takeshi Hara, Jun-ichi Kitagawa, Naoe Goto, Nobuhiro Kanemura, Senji Kasahara, Toshiki Yamada, Hisataka Moriwaki

Blood (2007) 110 (11): 1570.

https://doi.org/10.1182/blood.V110.11.1570.1570

Published: 2007

NARROW

A Randomized Phase II/III Study of R-THP-Cop Vs R-CHOP for Patients Younger Than 70 Years with DLBCL

Combination Of Indoleamine 2,3-Dioxygenase Inhibitor and Cytotoxic Agents Is a Novel Therapeutic Option For Non-Hodgkin Lymphoma

Serum IL-10 and IL-8 Among Variable Cytokines Derived From Helper T Cells Might Be Associated with Prognoses for Malignant Lymphoma Patients

Prognositc Inpact of Tumor-Infiltrating FOXP3 + Regulatory T Cells in DLBCL Treated with R-CHOP

Combination of Indoleamine 2,3-Dioxygenase Expression and L-Kynurenine Level Can Identify Truly Poor Prognosis Patients with Diffuse Large B-Cell Lymphoma

Tryptophan Catabolism Is Associated with the Prognosis of Patients with De Novo Acute Myeloid Leukemia,

Prognositc Inpact of Tumor-Infiltrating Cells Especially CD163 Positive Macrophage in DLBCL Treated with R-CHOP

Clinical Significance of Serum Concentration of L-Kynurenine for T-Cell Lymphoma Treated with CHOP

Serum Soluble Tumor Necrosis Factor Recepter 2 Levels Is Associated with the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Regimen

Clinical Significance of Small Intestinal Involvement Detected by Double-Balloon Enteroscopy In Patients with Non-Hodgkin's Lymphoma

Clinical Impact of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy In the Diagnosis of Patients with Lymphoma Who Have No Superficial Lymphadenopathies

Tryptophan Catabolism Is Associated with Clinical Outcome of Patients with Malignant Lymphoma

Expression of IDO (indoleamine 2,3-dioxygenase) In Blasts of Acute Myeloid Leukemia Patients Predicts Poor Clinical Outcome

Serum Soluble Interleukin-2 Level Determines Clinical Outcome In Patients with Follicular Lymphoma In Rituximab Era

Serum Interleukin-18 Level Determines Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma in Rituximab Era.

The Immunohistochemical Pattern of Indoleamine 2,3-Dioxygenase in Tumor Tissue Indicates the Prognosis of Patients with Diffuse Large B-Cell Lymphoma.

Serum Concentration of L-Kynurenine Can Determine Clinical Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

A Phase II Study of the Combination Chemotherapy Consisted of Rituximab and THP-COP Regimen as First-Line Treatment for Patients with Diffuse Large B-Cell Lymphoma

Synergistic Growth Inhibition by the Combination of Acyclic Retinoid Plus Vitamin K 2 in HL-60 Cells

Second Report of Clinical Significance of sFas for DLBCL Treated with CHOP and New Analysis of sFas for DLBCL Treated with R-CHOP.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only